LASIK in Patients with Rheumatic Diseases: A Pilot Study

详细信息	查看全文 | 推荐本文 |

• 作者：Jorge L. Alió ; Alberto Artola ; José ; I. Belda ; Juan J. Perez-Santonja ; Gonzalo Muñ ; oz ; Jaime Javaloy ; José ; L. Rodrí ; guez-Prats and Ahmed Galal
• 刊名：Ophthalmology
• 出版年：2005
• 期刊代码：211_01616420
• 类别：med
• 出版时间：2005
• 卷：112
• 期：11
• 页码：1948-1954
• 文件大小：286 K

摘要

Purpose

To investigate the safety of LASIK in patients with a known history of controlled rheumatic diseases.

Design

Retrospective consecutive observational clinical study.

Participants

Forty-two eyes (22 patients) known to have had a history of rheumatic diseases underwent LASIK. All patients had a history of controlled rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis, scleroderma, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease, arthritis, or Behçet’s disease.

Methods

Assessments were made preoperatively and at 1, 3, and 6 months postoperatively and included visual acuity (VA), refraction, keratometric readings, slit-lamp biomicroscopy, and corneal topography. All the patients underwent LASIK. Postoperative treatment included a topical steroid–antibiotic combination.

Main Outcome Measures

Visual acuity, refraction, keratometric readings, and slit-lamp biomicroscopy findings at 1, 3, and 6 months postoperatively.

Results

LASIK was performed uneventfully on all patients. The mean pre-LASIK spherical equivalent (SE) was −5.39±2.25, and the sixth month postoperative SE was −0.15±0.38 diopters (D) (P<0.001). Uncorrected VA 6 months after the LASIK procedure was 20/25. Enhancement procedures were performed in 6 of 42 eyes (14.3%) at variable times after the primary procedure. Postoperative follow-up showed development of a moderate degree of dry eye syndrome in 4 eyes (9.5%). Corneal haze, melting, flap, or interface complications were not observed in any of the study eyes.

Conclusions

In this small series, we found good outcomes when correcting refractive errors using LASIK in selected patients with controlled rheumatic diseases. In this series, a favorable postoperative visual outcome was obtained with no operative or postoperative vision-threatening complications.